Free Trial

Windward Capital Management Co. CA Has $23.29 Million Stock Position in Zoetis Inc. (NYSE:ZTS)

Zoetis logo with Medical background

Key Points

  • Windward Capital Management Co. CA holds a position of $23.29 million in Zoetis Inc., although it reduced its holdings by 1.6% in the first quarter.
  • Zoetis reported earnings of $1.76 per share for the last quarter, exceeding analysts' estimates, with a year-over-year revenue increase of 4.2% to $2.46 billion.
  • The company announced a quarterly dividend of $0.50 per share, reflecting an annualized dividend of $2.00 and a yield of 1.3%.
  • Want stock alerts on Zoetis? Get 5 Weeks of MarketBeat All Access for $5. Get My Stock Alerts.

Windward Capital Management Co. CA lowered its position in shares of Zoetis Inc. (NYSE:ZTS - Free Report) by 1.6% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 141,450 shares of the company's stock after selling 2,297 shares during the quarter. Zoetis accounts for 2.0% of Windward Capital Management Co. CA's holdings, making the stock its 18th biggest position. Windward Capital Management Co. CA's holdings in Zoetis were worth $23,290,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of the company. Vanguard Group Inc. boosted its holdings in shares of Zoetis by 0.5% in the 1st quarter. Vanguard Group Inc. now owns 41,556,164 shares of the company's stock valued at $6,842,222,000 after buying an additional 189,287 shares during the last quarter. Polen Capital Management LLC boosted its holdings in shares of Zoetis by 17.6% in the 1st quarter. Polen Capital Management LLC now owns 8,796,847 shares of the company's stock valued at $1,448,401,000 after buying an additional 1,313,653 shares during the last quarter. Northern Trust Corp lifted its holdings in Zoetis by 13.3% during the 4th quarter. Northern Trust Corp now owns 6,426,394 shares of the company's stock valued at $1,047,052,000 after purchasing an additional 755,893 shares during the last quarter. Goldman Sachs Group Inc. lifted its holdings in Zoetis by 2.2% during the 1st quarter. Goldman Sachs Group Inc. now owns 5,146,024 shares of the company's stock valued at $847,293,000 after purchasing an additional 109,791 shares during the last quarter. Finally, Unisphere Establishment lifted its holdings in Zoetis by 7.3% during the 4th quarter. Unisphere Establishment now owns 4,800,000 shares of the company's stock valued at $782,064,000 after purchasing an additional 325,000 shares during the last quarter. Institutional investors and hedge funds own 92.80% of the company's stock.

Zoetis Stock Up 0.7%

ZTS opened at $154.15 on Friday. Zoetis Inc. has a fifty-two week low of $139.70 and a fifty-two week high of $200.33. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.04 and a current ratio of 1.76. The company has a market capitalization of $68.32 billion, a P/E ratio of 26.53, a P/E/G ratio of 2.47 and a beta of 0.88. The stock has a fifty day moving average of $154.94 and a 200-day moving average of $159.13.

Zoetis (NYSE:ZTS - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.14. Zoetis had a return on equity of 56.90% and a net margin of 27.83%. The company had revenue of $2.46 billion during the quarter, compared to the consensus estimate of $2.41 billion. During the same quarter last year, the firm earned $1.56 earnings per share. The company's revenue was up 4.2% on a year-over-year basis. On average, equities analysts expect that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 3rd. Stockholders of record on Friday, July 18th will be issued a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, July 18th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.3%. Zoetis's dividend payout ratio (DPR) is currently 34.42%.

Insider Buying and Selling at Zoetis

In other news, EVP Roxanne Lagano sold 652 shares of Zoetis stock in a transaction on Tuesday, June 3rd. The stock was sold at an average price of $170.00, for a total transaction of $110,840.00. Following the completion of the sale, the executive vice president owned 15,129 shares of the company's stock, valued at approximately $2,571,930. This trade represents a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Corporate insiders own 0.18% of the company's stock.

Wall Street Analyst Weigh In

ZTS has been the subject of several research reports. Piper Sandler raised their price target on Zoetis from $210.00 to $215.00 and gave the company an "overweight" rating in a report on Monday, August 11th. Stifel Nicolaus downgraded Zoetis from a "buy" rating to a "hold" rating and cut their price target for the company from $165.00 to $160.00 in a report on Wednesday, June 18th. Leerink Partnrs downgraded Zoetis from a "strong-buy" rating to a "hold" rating in a report on Thursday, July 17th. UBS Group cut their price target on Zoetis from $189.00 to $170.00 and set a "neutral" rating for the company in a report on Wednesday, May 7th. Finally, Leerink Partners downgraded Zoetis from an "outperform" rating to a "market perform" rating and cut their price target for the company from $180.00 to $155.00 in a report on Thursday, July 17th. Four equities research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $202.43.

View Our Latest Research Report on ZTS

About Zoetis

(Free Report)

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.

Further Reading

Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc. (NYSE:ZTS - Free Report).

Institutional Ownership by Quarter for Zoetis (NYSE:ZTS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Zoetis Right Now?

Before you consider Zoetis, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zoetis wasn't on the list.

While Zoetis currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Follow the Money: 5 Stocks Institutions Are Buying NOW
Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines